Skip to main content
Erschienen in: Urolithiasis 5/2008

01.10.2008 | Original Paper

Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis

verfasst von: Clarita V. Odvina, John R. Poindexter, Roy D. Peterson, Joseph E. Zerwekh, Charles Y. C. Pak

Erschienen in: Urolithiasis | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

Hypercalciuria of intestinal origin has been linked with bone loss in calcium nephrolithiasis and idiopathic osteoporosis. This retrospective data analysis was performed to explore potential pathogenetic link between intestinal hyperabsorption of calcium and postmenopausal osteoporosis. Data were retrieved from postmenopausal women who were evaluated for osteoporosis or osteopenia at the Mineral Metabolism Clinic of UT Southwestern Medical Center. A total of 319 patients underwent the test of calciuric response to oral calcium load to obtain an indirect measure of intestinal calcium absorption. Serum and urinary biochemistry and L2–L4 bone mineral density (BMD) were compared between five quintiles of calciuric response. There was a statistically significant trend toward a rise in 24-h urinary calcium and a decrease in urinary deoxypyridinoline (DPD) and BMD, with increasing order of quintiles. The presentation of those in the 1st quintile was consistent with vitamin D insufficiency or deficiency, with impaired calcium absorption, secondary hyperparathyroidism, and stimulated bone turnover (high normal urinary DPD). In contrast, patients in the 5th quintile displayed a picture of absorptive hypercalciuria of stone disease, with intestinal hyperabsorption of calcium, high or high normal urinary calcium and suppressed bone turnover (low or low normal urinary DPD). Thus, the assessment of intestinal calcium absorption in a seemingly homogeneous group of postmenopausal women with osteoporosis or osteopenia revealed a spectrum of calciuric response whose extremes may represent two physiologically distinct subtypes that have important diagnostic and therapeutic implications.
Literatur
1.
Zurück zum Zitat Pietschmann F, Breslau NA, Pak CYC (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7:1383–1388PubMed Pietschmann F, Breslau NA, Pak CYC (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7:1383–1388PubMed
2.
Zurück zum Zitat Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G et al (2003) Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 16:260–266PubMed Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G et al (2003) Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 16:260–266PubMed
3.
Zurück zum Zitat Giannini S, Nobile M, Sartori L, Calò L, Tasca A, Dalle Carbonare L et al (1998) Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 50:94–100PubMed Giannini S, Nobile M, Sartori L, Calò L, Tasca A, Dalle Carbonare L et al (1998) Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 50:94–100PubMed
4.
Zurück zum Zitat Heller HJ, Zerwekh JE, Gottschalk FA, Pak CYC (2007) Increased bone resorption and reduced bone formation in moderate-severe absorptive hypercalciuria: bone histomorphometric analysis and alendronate challenge. Kidney Int 71:808–815. doi:10.1038/sj.ki.5002181 PubMedCrossRef Heller HJ, Zerwekh JE, Gottschalk FA, Pak CYC (2007) Increased bone resorption and reduced bone formation in moderate-severe absorptive hypercalciuria: bone histomorphometric analysis and alendronate challenge. Kidney Int 71:808–815. doi:10.​1038/​sj.​ki.​5002181 PubMedCrossRef
5.
Zurück zum Zitat Heilberg IP, Martini LA, Szejnfeld VL, Carvalho AB, Draibe SA, Ajzen H et al (1994) Bone disease in calcium stone forming patients. Clin Nephrol 42:175–182PubMed Heilberg IP, Martini LA, Szejnfeld VL, Carvalho AB, Draibe SA, Ajzen H et al (1994) Bone disease in calcium stone forming patients. Clin Nephrol 42:175–182PubMed
6.
Zurück zum Zitat Heiberg IP, Weisinger JR (2006) Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens 15:393–402 Heiberg IP, Weisinger JR (2006) Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens 15:393–402
7.
Zurück zum Zitat Malluce HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG (1980) Abnormal histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 50:654–658 Malluce HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG (1980) Abnormal histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 50:654–658
8.
Zurück zum Zitat Steiniche T, Moskilde L, Christensen MS, Melsen F (1988) A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. APMIS 97:309–316 Steiniche T, Moskilde L, Christensen MS, Melsen F (1988) A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. APMIS 97:309–316
9.
Zurück zum Zitat Weisinger JR, Alonzo E, Bellorin-Font F, Blasini AM, Rodriguez MA, Paz-Marinez V et al (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244–250. doi:10.1038/ki.1996.34 PubMedCrossRef Weisinger JR, Alonzo E, Bellorin-Font F, Blasini AM, Rodriguez MA, Paz-Marinez V et al (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244–250. doi:10.​1038/​ki.​1996.​34 PubMedCrossRef
10.
Zurück zum Zitat Zerwekh JE, Sakhee K, Breslau NA, Gottschalk F, Pak CYC (1992) Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int 2:128–134. doi:10.1007/BF01623819 PubMedCrossRef Zerwekh JE, Sakhee K, Breslau NA, Gottschalk F, Pak CYC (1992) Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int 2:128–134. doi:10.​1007/​BF01623819 PubMedCrossRef
11.
13.
Zurück zum Zitat Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G et al (2003) Hypercalciuria is a common and important finding in postmeopausal women with osteoporosis. Eur J Endocrinol 149:209–213. doi:10.1530/eje.0.1490209 PubMedCrossRef Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G et al (2003) Hypercalciuria is a common and important finding in postmeopausal women with osteoporosis. Eur J Endocrinol 149:209–213. doi:10.​1530/​eje.​0.​1490209 PubMedCrossRef
14.
Zurück zum Zitat Tannebaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D et al (2002) Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87:4431–4437. doi:10.1210/jc.2002-020275 CrossRef Tannebaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D et al (2002) Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87:4431–4437. doi:10.​1210/​jc.​2002-020275 CrossRef
15.
Zurück zum Zitat Feitag A, Barzel US (2002) Differential diagnosis of osteoporosis. Gerontology 48:90–102 Feitag A, Barzel US (2002) Differential diagnosis of osteoporosis. Gerontology 48:90–102
17.
Zurück zum Zitat Painter SE, Kleerekoper M, Camacho PM (2006) Secondary osteoporosis: a review of the recent evidence. Endocr Pract 12:436–445PubMed Painter SE, Kleerekoper M, Camacho PM (2006) Secondary osteoporosis: a review of the recent evidence. Endocr Pract 12:436–445PubMed
19.
Zurück zum Zitat Pak CYC, Kaplan R, Bone H, Townsend J, Waters O (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 292:497–500PubMed Pak CYC, Kaplan R, Bone H, Townsend J, Waters O (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 292:497–500PubMed
20.
Zurück zum Zitat Broadus AE, Dominguez D, Bartter FC (1978) Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. J Clin Endocrinol Metab 47:751–760PubMed Broadus AE, Dominguez D, Bartter FC (1978) Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. J Clin Endocrinol Metab 47:751–760PubMed
21.
Zurück zum Zitat Harvey JA, Zobitz MM, Pak CYC (1988) Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 3:253–258PubMedCrossRef Harvey JA, Zobitz MM, Pak CYC (1988) Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 3:253–258PubMedCrossRef
23.
Zurück zum Zitat Schuetter SA, Knowles JB (1988) Intestinal absorption of Ca(H2PO4)2 and Ca citrate compared by two methods. Am J Clin Nutr 47:884–888 Schuetter SA, Knowles JB (1988) Intestinal absorption of Ca(H2PO4)2 and Ca citrate compared by two methods. Am J Clin Nutr 47:884–888
26.
Zurück zum Zitat Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT et al (2005) Prevalence of vitamin D insufficiency among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215–3224. doi:10.1210/jc.2004-2364 PubMedCrossRef Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT et al (2005) Prevalence of vitamin D insufficiency among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215–3224. doi:10.​1210/​jc.​2004-2364 PubMedCrossRef
27.
28.
Zurück zum Zitat Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC (1977) The role of 1α, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59:756–760. doi:10.1172/JCI108696 PubMedCrossRef Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC (1977) The role of 1α, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59:756–760. doi:10.​1172/​JCI108696 PubMedCrossRef
29.
Zurück zum Zitat Broadus AE, Erickson SB, Gertner JM, Cooper K, Dobbins JW (1984) An experimental human model of 1, 25-dihydroxy vitamin D-mediated hypercalciuria. J Clin Endocrinol Metab 58:161–169PubMedCrossRef Broadus AE, Erickson SB, Gertner JM, Cooper K, Dobbins JW (1984) An experimental human model of 1, 25-dihydroxy vitamin D-mediated hypercalciuria. J Clin Endocrinol Metab 58:161–169PubMedCrossRef
30.
Zurück zum Zitat Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE (1984) Evidence of disordered control of 1, 25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 311:73–80PubMed Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE (1984) Evidence of disordered control of 1, 25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 311:73–80PubMed
31.
Zurück zum Zitat Breslau NA, Preminger GM, Adams BV, Otey J, Pak CYC (1992) Use of ketoconazole to probe the pathogenetic importance of 1, 25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75:1446–1452. doi:10.1210/jc.75.6.1446 PubMedCrossRef Breslau NA, Preminger GM, Adams BV, Otey J, Pak CYC (1992) Use of ketoconazole to probe the pathogenetic importance of 1, 25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75:1446–1452. doi:10.​1210/​jc.​75.​6.​1446 PubMedCrossRef
32.
Zurück zum Zitat Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA et al (2005) Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20:447–454. doi:10.1359/JBMR.041120 PubMedCrossRef Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA et al (2005) Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20:447–454. doi:10.​1359/​JBMR.​041120 PubMedCrossRef
33.
Zurück zum Zitat Reed BY, Gitomer WL, Heller HJ, Hsu MC, Lempke M, Padalino P et al (2002) Identification and characterization of a gene with base substitutions associated with absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87:1476–1485. doi:10.1210/jc.87.4.1476 PubMedCrossRef Reed BY, Gitomer WL, Heller HJ, Hsu MC, Lempke M, Padalino P et al (2002) Identification and characterization of a gene with base substitutions associated with absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87:1476–1485. doi:10.​1210/​jc.​87.​4.​1476 PubMedCrossRef
34.
Zurück zum Zitat Odvina CV, Zerwekh ZE, Rao DS, Maalouf N, Gottschalk F, Pak CYC (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1291–1301 Odvina CV, Zerwekh ZE, Rao DS, Maalouf N, Gottschalk F, Pak CYC (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1291–1301
Metadaten
Titel
Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis
verfasst von
Clarita V. Odvina
John R. Poindexter
Roy D. Peterson
Joseph E. Zerwekh
Charles Y. C. Pak
Publikationsdatum
01.10.2008
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 5/2008
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-008-0146-4

Weitere Artikel der Ausgabe 5/2008

Urolithiasis 5/2008 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.